Mesco Pharmaceuticals Limited announced audited standalone earnings results for the fourth quarter and full year ended March 31, 2019. For the quarter, the company reported Loss for the period was INR 18,135.3 million against INR 12,956.0 million a year ago. Basic loss per share was INR 0.01 against INR 0.01 a year ago. For the full year, the company reported Loss for the period was INR 409,803.3 million against INR 87,349.0 million a year ago. Basic loss per share was INR 0.2 against INR 0.04 a year ago.